Annexon biosciences to participate in the 43rd annual cowen healthcare conference

Brisbane, calif., feb. 27, 2023 (globe newswire) -- annexon, inc. (nasdaq: annx) a clinical-stage biopharmaceutical company developing a new class of complement medicines for patients with classical complement-mediated autoimmune, neurodegenerative and ophthalmic disorders, today announced that douglas love, president and chief executive officer, will participate in a fireside chat during the 43rd annual cowen healthcare conference on monday, march 6, 2023 at 1:30 p.m. et in boston.
ANNX Ratings Summary
ANNX Quant Ranking